Keywords: soliris, works, across, all, pnh, patient, subgroups

Soliris works across all PNH patient subgroups

Article | 18 June 2007

Print This

The USA's Alexion Pharmaceuticals says that strong results from three analyses of Phase III trials of Soliris (eculizumab) in paroxysmal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in